JANUS HENDERSON GROUP PLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 204 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2022. The put-call ratio across all filers is 1.05 and the average weighting 0.4%.

Quarter-by-quarter ownership
JANUS HENDERSON GROUP PLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$74,669,595
-47.8%
2,190,686
-51.1%
0.06%
-43.4%
Q2 2022$143,082,000
-26.3%
4,478,248
-20.1%
0.10%
+5.3%
Q1 2022$194,095,000
+20.9%
5,603,255
+2.2%
0.09%
+40.3%
Q4 2021$160,488,000
+0.4%
5,483,164
-12.6%
0.07%
-4.3%
Q3 2021$159,826,000
-26.0%
6,272,682
+1.7%
0.07%
-23.9%
Q2 2021$216,008,000
-9.9%
6,168,150
+4.9%
0.09%
-15.6%
Q1 2021$239,716,000
-7.2%
5,882,575
-1.4%
0.11%
-9.2%
Q4 2020$258,426,000
-13.6%
5,966,862
+10.0%
0.12%
-23.1%
Q3 2020$299,207,000
+4.5%
5,426,282
+19.6%
0.16%
-3.1%
Q2 2020$286,312,000
+23.1%
4,535,253
-0.4%
0.16%
+0.6%
Q1 2020$232,662,000
-2.4%
4,553,981
+51.9%
0.16%
+31.1%
Q4 2019$238,382,000
+100.6%
2,998,895
+22.4%
0.12%
+90.6%
Q3 2019$118,843,000
-7.1%
2,449,371
+0.7%
0.06%
-7.2%
Q2 2019$127,955,000
-3.9%
2,432,605
-3.3%
0.07%
-6.8%
Q1 2019$133,191,000
+28.6%
2,516,365
-0.3%
0.07%
+12.1%
Q4 2018$103,580,000
-16.6%
2,523,268
-22.8%
0.07%0.0%
Q3 2018$124,185,000
-33.9%
3,268,038
-21.3%
0.07%
-38.3%
Q2 2018$187,778,000
+5.0%
4,154,385
+12.2%
0.11%
+1.9%
Q1 2018$178,784,000
+50.0%
3,701,542
+22.2%
0.10%
+43.8%
Q4 2017$119,183,000
+171.2%
3,028,782
+114.0%
0.07%
+160.7%
Q3 2017$43,953,000
+63.3%
1,415,558
+43.8%
0.03%
+55.6%
Q2 2017$26,919,000984,2330.02%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q1 2022
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$680.00%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders